SurbhiSidanaMD

PubMed

• 1 citations
  Safety and efficacy of standard-of-care ciltacabtagene autoleucel for relapsed/refractory multiple myeloma.
  Surbhi Sidana, Krina K Patel, Lauren C Peres, Radhika Bansal, Mehmet H Kocoglu
  Blood. 2025-01-02
• T Cell-Redirecting Bispecific Antibodies in Multiple Myeloma: Optimal Dosing Schedule and Duration of Treatment.
  Niels W C J van de Donk, Leo Rasche, Surbhi Sidana, Sonja Zweegman, Alfred L Garfall
  Blood Cancer Discovery. 2024-11-01
• 3 citations
  A phase 1 clinical trial of NKTR-255 with CD19-22 CAR T-cell therapy for refractory B-cell acute lymphoblastic leukemia.
  Hrishikesh Srinagesh, Clayton Jackson, Parveen Shiraz, Nikeshan Jeyakumar, Mark Hamilton
  Blood. 2024-10-17

Journal Articles

• Relapse After Complete Response in Newly Diagnosed Multiple Myeloma: Implications of Duration of Response and Patterns of Relapse  
  Angela Dispenzieri, Francis K Buadi, Morie A Gertz, Martha Q Lacy, Nelson Leung, Amie L Fonder, Wilson I Gonsalves, Yi Lisa Hwa, Taxiarchis Kourelis, Surbhi Sidana, Ro..., Nature
• Primary Systemic Amyloidosis in Patients with Waldenström Macroglobulinemia  
  Angela Dispenzieri, Eli Muchtar, Ronald Go, Saurabh Zanwar, Surbhi Sidana, Francis Buadi, Stephen M Ansell, Prashant Kapoor, David Dingli, Thomas Habermann, Shaji Kuma..., Nature

Abstracts/Posters

• Favorable Long-Term Outcomes after Daratumumab Discontinuation in AL Amyloidosis Patients Achieving Deep Responses
  Surbhi Sidana, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Long-Term Outcomes and Organ Responses with Daratumumab Therapy in Previously Treated Patients with AL Amyloidosis
  Surbhi Sidana, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019

Lectures

• Quality of life (QOL) in patients undergoing CAR-T therapy versus stem cell transplant (SCT). 
  ASCO Annual Meeting 2019 - Chicago, IL - 6/1/2019
• Glycosylation of Immunoglobulin Light Chains Is Highly Prevalent in Cold Agglutinin Disease 
  61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
• Immunoglobulin Variable Gene Region (IGVL) Usage Correlates with Distinct Clinical Presentation in IgM Versus Non-IgM Light Chain Amyloidosis 
  61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019